Logo image of LILM

LILIUM NV (LILM) Stock Fundamental Analysis

USA - NASDAQ:LILM - NL0015000F41 - Common Stock

0.052 USD
-0.03 (-36.97%)
Last: 11/5/2024, 8:00:02 PM
0.0564 USD
+0 (+8.46%)
After Hours: 11/5/2024, 8:00:02 PM
Fundamental Rating

1

LILM gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 70 industry peers in the Aerospace & Defense industry. LILM may be in some trouble as it scores bad on both profitability and health. LILM does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year LILM has reported negative net income.
LILM had a negative operating cash flow in the past year.
LILM had negative earnings in each of the past 5 years.
In the past 5 years LILM always reported negative operating cash flow.
LILM Yearly Net Income VS EBIT VS OCF VS FCFLILM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 -100M -200M -300M -400M

1.2 Ratios

Looking at the Return On Assets, with a value of -124.74%, LILM is doing worse than 93.94% of the companies in the same industry.
LILM's Return On Equity of -1050.03% is on the low side compared to the rest of the industry. LILM is outperformed by 83.33% of its industry peers.
Industry RankSector Rank
ROA -124.74%
ROE -1050.03%
ROIC N/A
ROA(3y)-102.55%
ROA(5y)-98.21%
ROE(3y)-431.46%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LILM Yearly ROA, ROE, ROICLILM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 200 -200 -400 -600 -800 -1K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for LILM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LILM Yearly Profit, Operating, Gross MarginsLILM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 -200K -400K -600K -800K

1

2. Health

2.1 Basic Checks

LILM has more shares outstanding than it did 1 year ago.
The debt/assets ratio for LILM has been reduced compared to a year ago.
LILM Yearly Shares OutstandingLILM Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M
LILM Yearly Total Debt VS Total AssetsLILM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

LILM has an Altman-Z score of -7.40. This is a bad value and indicates that LILM is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of LILM (-7.40) is worse than 90.91% of its industry peers.
A Debt/Equity ratio of 0.22 indicates that LILM is not too dependend on debt financing.
LILM has a Debt to Equity ratio of 0.22. This is in the better half of the industry: LILM outperforms 74.24% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Altman-Z -7.4
ROIC/WACCN/A
WACCN/A
LILM Yearly LT Debt VS Equity VS FCFLILM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 200M -200M

2.3 Liquidity

LILM has a Current Ratio of 0.84. This is a bad value and indicates that LILM is not financially healthy enough and could expect problems in meeting its short term obligations.
LILM has a worse Current ratio (0.84) than 87.88% of its industry peers.
A Quick Ratio of 0.84 indicates that LILM may have some problems paying its short term obligations.
LILM's Quick ratio of 0.84 is on the low side compared to the rest of the industry. LILM is outperformed by 68.18% of its industry peers.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.84
LILM Yearly Current Assets VS Current LiabilitesLILM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 100M 200M 300M

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 11.14% over the past year.
EPS 1Y (TTM)11.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.26%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 22.80% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y23.65%
EPS Next 2Y13.68%
EPS Next 3Y9.58%
EPS Next 5Y22.8%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LILM Yearly Revenue VS EstimatesLILM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B
LILM Yearly EPS VS EstimatesLILM Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1 1.5

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LILM. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LILM. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LILM Price Earnings VS Forward Price EarningsLILM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LILM Per share dataLILM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.68%
EPS Next 3Y9.58%

0

5. Dividend

5.1 Amount

No dividends for LILM!.
Industry RankSector Rank
Dividend Yield N/A

LILIUM NV

NASDAQ:LILM (11/5/2024, 8:00:02 PM)

After market: 0.0564 +0 (+8.46%)

0.052

-0.03 (-36.97%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)09-25 2024-09-25/bmo
Earnings (Next)12-27 2024-12-27/bmo
Inst Owners2.7%
Inst Owner Change0%
Ins Owners0.06%
Ins Owner Change0%
Market Cap32.90M
Analysts76.36
Price Target1.64 (3053.85%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-16.77%
PT rev (3m)12.17%
EPS NQ rev (1m)11.54%
EPS NQ rev (3m)11.54%
EPS NY rev (1m)15.02%
EPS NY rev (3m)15.02%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.84
P/tB 0.85
EV/EBITDA N/A
EPS(TTM)-0.75
EYN/A
EPS(NY)-0.59
Fwd EYN/A
FCF(TTM)-0.44
FCFYN/A
OCF(TTM)-0.39
OCFYN/A
SpS0
BVpS0.06
TBVpS0.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -124.74%
ROE -1050.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-102.55%
ROA(5y)-98.21%
ROE(3y)-431.46%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 226.49%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.84
Quick Ratio 0.84
Altman-Z -7.4
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)208.53%
Cap/Depr(5y)208.96%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.26%
EPS Next Y23.65%
EPS Next 2Y13.68%
EPS Next 3Y9.58%
EPS Next 5Y22.8%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y2.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-17.61%
EBIT Next 3Y12.51%
EBIT Next 5Y24.34%
FCF growth 1Y2.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y9.96%
OCF growth 3YN/A
OCF growth 5YN/A